<DOC>
	<DOCNO>NCT02419677</DOCNO>
	<brief_summary>The purpose study determine whether combine radiofrequency ablation ( RFA ) cytokine-induced killer cell ( CIK ) transfusion prolong survival patient colorectal cancer liver metastasis ( CRCLM ) .</brief_summary>
	<brief_title>Radiofrquency Ablation Combined With Cytokine-induced Killer Cells Colorectal Cancer Liver Metastases</brief_title>
	<detailed_description>The primary objective evaluate whether RFA follow CIK transfusion prolong survival patient resectable CRCLM .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<criteria>Patients histologically confirm adenocarcinoma Primary lesion ( colorectal cancer ) resect Must undergone prior complete resection primary tumor ; liver metastasis Must resectable accessible radiofrequency ablation ( Five less lung metastasis measure 5 cm small ) . Serum bilirubin level 2.0 mg/dl less . Performance status 0 1 . Expected survival 1 year . Informed consent patient . With extrahepatic metastasis With neoplastic disease measurable treated colorectal cancer .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>radiofrequency ablation</keyword>
	<keyword>cytokine-induced killer cell</keyword>
	<keyword>colorectal cancer iver metastasis</keyword>
</DOC>